ABBV-514

DB17586InvestigationalProtein Based Therapies

ABBV-514 is in development for the treatment of non-small cell lung cancer (NSCLC) and head and neck squamous cell carcinoma (HNSCC) as a single agent and in combination with a...

Mechanism: Pharmacologically active on C-C chemokine receptor type 9
Curator reviewed
Code names: ABBV-514

Resolves to

Targets

P51686CCR9

What you can answer from here — as of May 09, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

2+ReferencesStructured and connected to the statements they support

Which drugs share a target with ABBV-514, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account